What do the high cost of cancer drug development and inconsistencies in many cancer research studies have in common? The most direct answer is that the in vitro models currently in use do not ...

In this Application Note, Sartorius describes the use of the Incucyte® Live-Cell Analysis System and Incucyte® 3D Multi-Tumor Spheroid Assays to study the growth of 3D tumor multi-spheroids in ...

Three-dimensional cancer cell models, like tumoroids and spheroids, closely mimic the structure and behavior of tumors, making them powerful tools in cancer research and drug development. However, ...

The cost of bringing a new drug to the market has recently been estimated by Forbes Magazine at $5 billion. This figure derives in large part from high attrition rates in the drug development pipeline ...

A growing body of evidence indicates that studies utilizing organoids and microtissues yield more predictive and translational insights compared to traditional two-dimensional (2D) monolayer cell ...